ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,822.30
-0.12%
S&P ASX All Technology
3,081.10
0.25%
Brent Oil
87.175
-0.18%
US Dollar vs AUD
1.48265
-0.29%
Bitcoin
55,375.37
-2.81%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Vistin Pharma Asa (0RAM) Share Price

Vistin Pharma Asa

Vistin Pharma Asa (0RAM)

LSE
11.25
0.00
( 0.00% )
Updated: 10:00:00
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
11.25
Bid
0.00
Offer
0.00
Volume
0.00
0.00 Day's Range 0.00
11.25 52 Week Range 11.25
Market Cap
498.881M
Previous Close
11.25
Open
-
Last Trade
(O)
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
2,939
Shares Outstanding
44,345,000
Dividend Yield
-
PE Ratio
10.93
Earnings Per Share (EPS)
1.03
Revenue
438.33M
Net Profit
45.64M

About Vistin Pharma Asa

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.vistin.com
Headquarters
Oslo, Nor
Founded
1970
Vistin Pharma Asa is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0RAM. The last closing price for Vistin Pharma Asa was kr11.25. Over the last year, Vistin Pharma Asa shares have traded in a share price range of kr 11.25 to kr 11.25.

Vistin Pharma Asa currently has 44,345,000 shares in issue. The market capitalisation of Vistin Pharma Asa is kr498.88 million. Vistin Pharma Asa has a price to earnings ratio (PE ratio) of 10.93.

0RAM Latest News

More News

Ex dividend NOK 0.50 today

Ex dividend NOK 0.50 today The shares in Vistin Pharma ASA will be traded ex dividend NOK 0.50 as from today, 05.06.2024.

05 June 2024
UK Regulatory

Vistin Pharma ASA: Minutes from the annual general meeting 2024

Vistin Pharma ASA: Minutes from the annual general meeting 2024 Oslo, Norway, 23 May 2024 Vistin Pharma ASA (OSE: VISTN), please find attached the minutes from the annual general meeting held...

23 May 2024
UK Regulatory

Disclosure of voting rights at AGM in Vistin Pharma ASA

Disclosure of voting rights at AGM in Vistin Pharma ASA Oslo, Norway, 23 May 2024 In relation to the Annual General Meeting in Vistin Pharma ASA (OSE: VISTN), on the 23th of May, the Company's...

23 May 2024
UK Regulatory

Vistin Pharma ASA: Notice of Annual General Meeting 23 May 2024

Vistin Pharma ASA: Notice of Annual General Meeting 23 May 2024 Oslo, Norway, 30 April 2024 Vistin Pharma ASA (OSE: VISTN), please find attached the call for the Annual General Meeting in Vistin...

30 April 2024
UK Regulatory

Vistin Pharma ASA: Annual Report 2023

Vistin Pharma ASA: Annual Report 2023 Oslo, Norway, 24 April 2024 Please find attached the Annual Report for 2023 for Vistin Pharma ASA. There are no material changes in the financial statements...

25 April 2024
UK Regulatory

Vistin Pharma ASA: First quarter 2024 financial results

Vistin Pharma ASA: First quarter 2024 financial results Oslo, Norway, 24th of April 2024 Vistin Pharma ASA (VISTN) today announces the financial results for the first quarter of 2024. Revenue in...

24 April 2024
UK Regulatory

Vistin Pharma ASA: Invitation to Q1 2024 conference call

Vistin Pharma ASA: Invitation to Q1 2024 conference call Oslo, Norway, 16 April 2024 Vistin Pharma ASA will release its first quarter results on Wednesday 24th of April 2024. Vistin Pharma will...

16 April 2024
UK Regulatory

Vistin Pharma ASA: Mandatory notification of trade

Vistin Pharma ASA: Mandatory notification of trade Pactum Vekst AS has on March 22, 2024 sold 527 960 shares in Vistin Pharma ASA at a price of NOK 22,10 per share. Espen W. Marcussen, Chair of...

23 March 2024
UK Regulatory
Period †ChangeChange %OpenHighLowAvg. Daily VolVWAP
10011.2511.2511.25100011.25DE
40011.2511.2511.25325011.25DE
120011.2511.2511.25293911.25DE
260011.2511.2511.25210611.25DE
520011.2511.2511.25207611.25DE
1560011.2511.2511.25170311.25DE
2600011.2511.2511.25234511.25DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MRQOMRG Metals Limited
AUD 0.002
(100.00%)
98.55M
PNTOAPanther Metals Ltd
AUD 0.002
(100.00%)
550k
M2MOMT Malcolm Mines NL
AUD 0.01
(66.67%)
4.08M
CLZClassic Minerals Limited
AUD 0.0015
(50.00%)
20.93M
EQSEquity Story Group Ltd
AUD 0.022
(46.67%)
376.59k
TMGODTrigg Minerals Ltd
AUD 0.001
(-50.00%)
16.03M
SHOSportshero Limited
AUD 0.003
(-40.00%)
3.14M
ME1Melodiol Global Health Ltd
AUD 0.002
(-33.33%)
16.97M
LITOALithium Australia Ltd
AUD 0.002
(-33.33%)
100.65k
BPMOBPM Minerals Limited
AUD 0.005
(-28.57%)
16k
MRQOMRG Metals Limited
AUD 0.002
(100.00%)
98.55M
MRQMRG Metals Ltd
AUD 0.004
(-27.27%)
80.64M
M2MMt Malcolm Mines NL
AUD 0.041
(20.59%)
45.99M
PUAPeak Minerals Limited
AUD 0.0045
(28.57%)
39M
AL3AML3D Limited
AUD 0.21
(23.53%)
37.15M

Discussion

View Full Feed
subslover subslover 3 minutes ago
Maybe?
QLGN
B_B! B_B! 3 minutes ago
Hydrogen fuel consumption rises almost 50% in South Korea amid H2 bus boom
Environment ministry says it expects cumulative H2 bus registrations to exceed 1,000 by the end of this week
Leigh Collins 5 July 2024

The consumption of hydrogen fuel by road vehicles in South
PLUG
power11 power11 3 minutes ago
OH, OK, SO YOU WANT TO WAIST SIX MORE MONTHS OF YOUR LIFE, AMAZING !!
WILL THEY EVER LEARN ???????????????????? NOP
SHMP
CaptainObvious CaptainObvious 3 minutes ago
"Delusional"
NWBO
Penny Stocks 2.0 Penny Stocks 2.0 3 minutes ago
$GRST .0008 A Must Buy »»

$11.5m Assets
$5.5m Revenue
$1.5m Profit
Pace for $3.6m EBITDA 2024

Investment Banker Offer
LIMIT BUY .0012 to 8,000 Wallstreet Investors when PPS hits the Limit Price

Looking at $189,000,000 Valuation
GRST
Penny Stocks 2.0 Penny Stocks 2.0 4 minutes ago
$GRST .0008 A Must Buy »»

$11.5m Assets
$5.5m Revenue
$1.5m Profit
Pace for $3.6m EBITDA 2024

Investment Banker Offer
LIMIT BUY .0012 to 8,000 Wallstreet Investors when PPS hits the Limit Price

Looking at $189,000,000 Valuation
GRST
Uncleval Uncleval 4 minutes ago
Ok cool, you will explain more to the judge when the class action lawsuit hits you. Lawyer up sir..
LEAS
straightword straightword 4 minutes ago
The truth hurts doesn't it? My challenge stands/ Prove me wrong then.
VPLM
ALDRADJKD123 ALDRADJKD123 4 minutes ago
Kamala Harris caught spreading lies about Trump

https://youtu.be/w16Je1GYxi8?si=hqstUwyJzK3SL_It
DJT
elks elks 4 minutes ago
Will it rip to 60 cents ?
QLGN
BullNBear52 BullNBear52 5 minutes ago
~~COMPX 7/5/2024~~~~~~~

Previous Close

18,188.30 +159.54

18252 BullNBear52
18052 SSKILLZ1
COMP
930 930 5 minutes ago
https://www.tipranks.com/news/the-fly/kulr-technology-files-35m-mixed-securities-shelf?mod=mw_quote_news
KULR
tulla236a tulla236a 5 minutes ago
less than a year ago we were at the $40 range after its was beaten down. i wonder how long they can continue this? i can’t wait to see how they have done their corruption and how much it has cost them, and of course the players.
AMC
RickNagra RickNagra 5 minutes ago
Oh wow. Today will be a great day. Sun is up birds are chirping squirrels are eating acorns wolves are howling at the moon folks are dining at Burger King and whales are getting ready to slap the ASK. Oh wow. Oh boy oh girl.
DBMM
poguemahone poguemahone 5 minutes ago
Yes, I refer to it as “blame the referee” syndrome. We only lose the game because of the referee, not because our team didn’t execute.
AVXL
ALDRADJKD123 ALDRADJKD123 6 minutes ago
Was Joan Rivers right about everything

https://youtu.be/c8a4KLVGIM8?si=EOmEaJemvgV0-Rxg
DJT
Hi_Lo Hi_Lo 6 minutes ago
Because of this, CNNA won't be able to get a Form 10 Registration approved by the SEC until the miss8 g financials are filed. This means that CNNA won't get any corporate actions such as a merger or name change approved by SEC/FINRA.

Should read...

Because of this, GMNI
CNNA GMNI
elks elks 6 minutes ago
Looking for a dip jump in.
QLGN
trader59 trader59 6 minutes ago
LOL…
Keep trying to divert attention. Here’s where you’d been told the RS was happening, but tried to get everyone to ignore it:

https://stocktwits.com/Benfishingallday/message/570259858

Gig’s up.
LEAS
BullNBear52 BullNBear52 6 minutes ago
F is like a ship lost at sea. Someday they'll figure out how to get back to port. I've owned it off and on since it traded at a buck and it has paid for 2 new Fords. I now own 3 including the Fusion

My cost basis for ARM is in the $70s. They benefited when NVDA split and it looked ch
NVDA
crescentmotor crescentmotor 6 minutes ago
They [the FDA] will view the SAVA Phase 3 trial methodologies with the highest level of skepticism.

Agree and think that is a given. The RETHINK results will need to be successful and stellar to have a chance to remove all the hangover in place.
AVXL
glenn1919 glenn1919 7 minutes ago
SING.......................ACHR.................https://stockcharts.com/h-sc/ui?s=ACHR&p=W&b=5&g=0&id=p86431144783
https://stockcharts.com/h-sc/ui?s=SING&p=W&b=5&g=0&id=p86431144783
ACHR
Skynet11 Skynet11 7 minutes ago
That's good to see. I've got that July date marked down :)
YCRM
crazy horse 0 crazy horse 0 7 minutes ago
❗️"Rishi Sunak is done.
https://t.me/AussieCossack/19373
He admitted his party's defeat in the elections and will resign as prime minister.

The West must understand that this will happen to everyone who promises to support Ukraine to the end and wants to defeat Russia.

Your Recent History

LSE
0RAM
Vistin Pharma Asa
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved